Brian Livingston of Oaklins Smith & Williamson takes us through the sale of The MOLE Clinic
Tech and a proven roll-out model were crucial factors in the sale of The MOLE Clinic. Brian Livingston talks through the deal.
We advised the owners of The MOLE Clinic on its sale to TriSpan-backed Sk:n, the UK’s largest network of specialist skin care clinics, which completed in August 2020. The MOLE Clinic has five London clinics, and specialises in skin cancer screening, diagnosis and treatment services for private patients and to the NHS. The value of the deal is undisclosed, but to give an idea of size, the business screens over 30,000 patients annually. The deal enhanced Sk:n’s traditional cosmetic offering into this specialist medical area. The MOLE Clinic also offers tele-dermatology to GPs nationally.
I’ve known The MOLE Clinic since its managing director Iain Mack, previously a successful lawyer in Glasgow, founded the business in 2003. One of the London clinics is next door to us in Moorgate. We got to know the business better as it developed, and when Iain received a number of approaches, he came to talk to us. There were several bids from UK and overseas private equity and private equity-backed strategic investors.